Factors associated with insufficient response to acute treatment of migraine in Japan: analysis of real-world data from the Adelphi Migraine Disease Specific Programme

Abstract Background Real-world data on sufficient/insufficient response, and predictors of insufficient response, to acute treatments for migraine are limited in Japan. This study aimed to identify factors associated with insufficient response to acute treatment of migraine by exploring significant...

Full description

Bibliographic Details
Main Authors: Koichi Hirata, Kaname Ueda, Wenyu Ye, Yongin Kim, Mika Komori, James Jackson, Sarah Cotton, Narayan Rajan, Tamas Treuer
Format: Article
Language:English
Published: BMC 2020-07-01
Series:BMC Neurology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12883-020-01848-4
_version_ 1819113171042959360
author Koichi Hirata
Kaname Ueda
Wenyu Ye
Yongin Kim
Mika Komori
James Jackson
Sarah Cotton
Narayan Rajan
Tamas Treuer
author_facet Koichi Hirata
Kaname Ueda
Wenyu Ye
Yongin Kim
Mika Komori
James Jackson
Sarah Cotton
Narayan Rajan
Tamas Treuer
author_sort Koichi Hirata
collection DOAJ
description Abstract Background Real-world data on sufficient/insufficient response, and predictors of insufficient response, to acute treatments for migraine are limited in Japan. This study aimed to identify factors associated with insufficient response to acute treatment of migraine by exploring significant differences between people with migraine who sufficiently/insufficiently respond to prescribed acute treatment in Japan. Methods This was a retrospective analysis of 2014 Adelphi Migraine Disease Specific Programme cross-sectional survey data collected from physicians and their consulting adult patients with migraine in Japan. Insufficient responders to prescribed acute treatment were patients who achieved headache pain freedom within 2 h of acute treatment in no more than three of their last five migraine attacks. Factors associated with insufficient response to prescribed acute migraine treatment were identified using backward logistic regression. Results Overall, 227/538 (42.2%) patients were classified as insufficient responders to prescribed acute migraine treatment. Significantly more insufficient responders than sufficient responders had consulted a neurologist or a migraine/headache specialist, and had chronic migraine or medication-overuse or tension-type headaches (p < 0.05). More insufficient responders than sufficient responders reported taking acute treatment when/after the pain started (77.0 vs. 68.9%) than at first sign of migraine (p < 0.05). Compared with sufficient responders, insufficient responders reported a significantly higher mean ± standard deviation (SD) Migraine Disability Assessment total score (12.7 ± 23.3 vs. 5.8 ± 10.4, p < 0.001) and lower quality of life (EuroQol-5 Dimensions utility score 0.847 ± 0.19 vs. 0.883 ± 0.16, p = 0.024). Factors significantly associated with insufficient response to acute treatment included seeing a neurologist versus an internist (odds ratio [OR] 1.93; 95% confidence interval [CI] 1.29–2.88; p = 0.002), taking acute medication when/after pain started versus at first sign of migraine (OR 1.65; 95% CI 1.05–2.60; p = 0.030), a higher MIDAS total score (OR 1.04; 95% CI 1.02–1.06; p < 0.001), and presence of comorbid cardiovascular disease (OR 0.53; 95% CI 0.28–0.98; p = 0.044). Conclusions Many people with migraine in Japan struggle to adequately treat migraine attacks with prescribed acute medication and exhibit high levels of unmet need for acute treatment. Optimized management strategies utilizing existing therapeutic options as well as additional effective therapeutic options for migraine are required to improve symptoms and quality of life.
first_indexed 2024-12-22T04:25:09Z
format Article
id doaj.art-d21a178688634026b194250f283b3e13
institution Directory Open Access Journal
issn 1471-2377
language English
last_indexed 2024-12-22T04:25:09Z
publishDate 2020-07-01
publisher BMC
record_format Article
series BMC Neurology
spelling doaj.art-d21a178688634026b194250f283b3e132022-12-21T18:39:11ZengBMCBMC Neurology1471-23772020-07-0120111110.1186/s12883-020-01848-4Factors associated with insufficient response to acute treatment of migraine in Japan: analysis of real-world data from the Adelphi Migraine Disease Specific ProgrammeKoichi Hirata0Kaname Ueda1Wenyu Ye2Yongin Kim3Mika Komori4James Jackson5Sarah Cotton6Narayan Rajan7Tamas Treuer8Department of Neurology, Dokkyo Medical UniversityEli Lilly Japan K.KEli Lilly and CompanyEli Lilly and CompanyEli Lilly Japan K.KAdelphi Real WorldAdelphi Real WorldEli Lilly AustraliaLilly Hungária KftAbstract Background Real-world data on sufficient/insufficient response, and predictors of insufficient response, to acute treatments for migraine are limited in Japan. This study aimed to identify factors associated with insufficient response to acute treatment of migraine by exploring significant differences between people with migraine who sufficiently/insufficiently respond to prescribed acute treatment in Japan. Methods This was a retrospective analysis of 2014 Adelphi Migraine Disease Specific Programme cross-sectional survey data collected from physicians and their consulting adult patients with migraine in Japan. Insufficient responders to prescribed acute treatment were patients who achieved headache pain freedom within 2 h of acute treatment in no more than three of their last five migraine attacks. Factors associated with insufficient response to prescribed acute migraine treatment were identified using backward logistic regression. Results Overall, 227/538 (42.2%) patients were classified as insufficient responders to prescribed acute migraine treatment. Significantly more insufficient responders than sufficient responders had consulted a neurologist or a migraine/headache specialist, and had chronic migraine or medication-overuse or tension-type headaches (p < 0.05). More insufficient responders than sufficient responders reported taking acute treatment when/after the pain started (77.0 vs. 68.9%) than at first sign of migraine (p < 0.05). Compared with sufficient responders, insufficient responders reported a significantly higher mean ± standard deviation (SD) Migraine Disability Assessment total score (12.7 ± 23.3 vs. 5.8 ± 10.4, p < 0.001) and lower quality of life (EuroQol-5 Dimensions utility score 0.847 ± 0.19 vs. 0.883 ± 0.16, p = 0.024). Factors significantly associated with insufficient response to acute treatment included seeing a neurologist versus an internist (odds ratio [OR] 1.93; 95% confidence interval [CI] 1.29–2.88; p = 0.002), taking acute medication when/after pain started versus at first sign of migraine (OR 1.65; 95% CI 1.05–2.60; p = 0.030), a higher MIDAS total score (OR 1.04; 95% CI 1.02–1.06; p < 0.001), and presence of comorbid cardiovascular disease (OR 0.53; 95% CI 0.28–0.98; p = 0.044). Conclusions Many people with migraine in Japan struggle to adequately treat migraine attacks with prescribed acute medication and exhibit high levels of unmet need for acute treatment. Optimized management strategies utilizing existing therapeutic options as well as additional effective therapeutic options for migraine are required to improve symptoms and quality of life.http://link.springer.com/article/10.1186/s12883-020-01848-4Adelphi Migraine Disease Specific ProgrammeJapanMigraineQuality of lifeRetrospective studyTreatment satisfaction
spellingShingle Koichi Hirata
Kaname Ueda
Wenyu Ye
Yongin Kim
Mika Komori
James Jackson
Sarah Cotton
Narayan Rajan
Tamas Treuer
Factors associated with insufficient response to acute treatment of migraine in Japan: analysis of real-world data from the Adelphi Migraine Disease Specific Programme
BMC Neurology
Adelphi Migraine Disease Specific Programme
Japan
Migraine
Quality of life
Retrospective study
Treatment satisfaction
title Factors associated with insufficient response to acute treatment of migraine in Japan: analysis of real-world data from the Adelphi Migraine Disease Specific Programme
title_full Factors associated with insufficient response to acute treatment of migraine in Japan: analysis of real-world data from the Adelphi Migraine Disease Specific Programme
title_fullStr Factors associated with insufficient response to acute treatment of migraine in Japan: analysis of real-world data from the Adelphi Migraine Disease Specific Programme
title_full_unstemmed Factors associated with insufficient response to acute treatment of migraine in Japan: analysis of real-world data from the Adelphi Migraine Disease Specific Programme
title_short Factors associated with insufficient response to acute treatment of migraine in Japan: analysis of real-world data from the Adelphi Migraine Disease Specific Programme
title_sort factors associated with insufficient response to acute treatment of migraine in japan analysis of real world data from the adelphi migraine disease specific programme
topic Adelphi Migraine Disease Specific Programme
Japan
Migraine
Quality of life
Retrospective study
Treatment satisfaction
url http://link.springer.com/article/10.1186/s12883-020-01848-4
work_keys_str_mv AT koichihirata factorsassociatedwithinsufficientresponsetoacutetreatmentofmigraineinjapananalysisofrealworlddatafromtheadelphimigrainediseasespecificprogramme
AT kanameueda factorsassociatedwithinsufficientresponsetoacutetreatmentofmigraineinjapananalysisofrealworlddatafromtheadelphimigrainediseasespecificprogramme
AT wenyuye factorsassociatedwithinsufficientresponsetoacutetreatmentofmigraineinjapananalysisofrealworlddatafromtheadelphimigrainediseasespecificprogramme
AT yonginkim factorsassociatedwithinsufficientresponsetoacutetreatmentofmigraineinjapananalysisofrealworlddatafromtheadelphimigrainediseasespecificprogramme
AT mikakomori factorsassociatedwithinsufficientresponsetoacutetreatmentofmigraineinjapananalysisofrealworlddatafromtheadelphimigrainediseasespecificprogramme
AT jamesjackson factorsassociatedwithinsufficientresponsetoacutetreatmentofmigraineinjapananalysisofrealworlddatafromtheadelphimigrainediseasespecificprogramme
AT sarahcotton factorsassociatedwithinsufficientresponsetoacutetreatmentofmigraineinjapananalysisofrealworlddatafromtheadelphimigrainediseasespecificprogramme
AT narayanrajan factorsassociatedwithinsufficientresponsetoacutetreatmentofmigraineinjapananalysisofrealworlddatafromtheadelphimigrainediseasespecificprogramme
AT tamastreuer factorsassociatedwithinsufficientresponsetoacutetreatmentofmigraineinjapananalysisofrealworlddatafromtheadelphimigrainediseasespecificprogramme